Business
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year
Full year fiscal 2025 revenue from continuing operations increased 6%; constant currency organic revenue growth was 6% Full year fiscal 2025 as reported diluted EPS from continuing operations increased to $6.16; adjusted EPS per diluted share increased to $9.22Fiscal 2026 outlook provided DUBLIN, IRELAND, May 14, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 fourth quarter and full year ended March 31, 2025. Tota
About this update from Steris Plc (ireland)
[{"type":"image","alt":"STERIS plc","displaySize":"","headline":null,"caption":"STERIS plc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":49,"url":"https://media.zenfs.com/en/globenewswire.com/61c0b036d78c693a74a778c5841207dc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_V2VVDc8.9gnCQDp8k6Yag--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTY5O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/61c0b036d78c693a74a778c5841207dc","width":300,"height":49}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Full year fiscal 2025 revenue from continuing operations increased 6%; constant currency organic revenue growth was 6% ","length":118,"tagName":"p"}]},{"val":[{"type":"text","content":"Full year fiscal 2025 as reported diluted EPS from continuing operations increased to $6.16; adjusted EPS per diluted share increased to $9.22","length":142,"tagName":"p"}]},{"val":[{"type":"text","content":"Fiscal 2026 outlook provided","length":28,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":288,"olType":false},{"type":"text","content":"DUBLIN, IRELAND, May 14, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 fourth quarter and full year ended March 31, 2025. Total revenue from continuing operations for the fourth quarter of fiscal 2025 increased 4% to $1.5 billion compared with $1.4 billion in the fourth quarter of fiscal 2024. Constant currency organic revenue growth from continuing operations for the fourth quarter was 6%.","length":477,"tagName":"p"},{"type":"text","content":"Revenue from continuing operations for fiscal 2025 increased 6% to $5.5 billion compared with $5.1 billion in fiscal 2024. Constant currency organic revenue growth from continuing operations for fiscal 2025 was 6%.","length":214,"tagName":"p"},{"type":"text","content":"“Fiscal 2025 was another record year,” said Dan Carestio, President and CEO of STERIS. “We continue to benefit from our diversified Customer base and growth in global procedure volumes. We appreciate the efforts of our global Associates who continue to put Customers first. We look forward to another successful year in fiscal 2026.”","length":333,"tagName":"p"},{"type":"text","content":"Total Company Fourth Quarter and Full Year Results from Continuing OperationsAs reported, net...